tiprankstipranks
Trending News
More News >
Zenas BioPharma, Inc. (ZBIO)
NASDAQ:ZBIO
US Market

Zenas BioPharma, Inc. (ZBIO) Income Statement

Compare
69 Followers

Zenas BioPharma, Inc. Income Statement

Last quarter (Q4 2024), Zenas BioPharma, Inc.'s total revenue was $5.00M, an increase of Infinity% from the same quarter last year. In Q4, Zenas BioPharma, Inc.'s net income was $-52.60M. See Zenas BioPharma, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 5.00M$ 50.00M$ 0.00
Gross Profit
$ 5.00M$ 50.00M$ 0.00
Operating Expenses
$ 168.89M$ 87.15M$ 76.20M
Depreciation and Amortization
$ 0.00$ 113.00K$ 78.00K
EBITDA
$ -163.89M$ -27.03M$ -75.12M
Operating Income
$ -163.89M$ -37.15M$ -76.20M
Other Income/Expenses
$ 7.33M$ 324.00K$ -43.08M
Pretax Income
$ -156.56M$ -36.82M$ -119.28M
Net Income
$ -156.13M$ -37.12M$ -119.28M
Per Share Metrics
Basic EPS
$ -3.76$ -0.97$ -3.11
Diluted EPS
$ -3.76$ -0.97$ -3.11
Weighted Average Shares Outstanding
41.79M 38.32M 38.32M
Weighted Average Shares Outstanding (Diluted)
41.79M 38.32M 38.32M
Currency in USD

Zenas BioPharma, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis